Elaine Snowhill
About
Elaine Snowhill is from Eugene, Oregon, United States. Elaine works in the following industries: "Biotechnology Research". Elaine is currently Vice President, Clinical Operations at Verndari, Inc., located in Remote. In Elaine's previous role as a Collaborative Problem Solving Coach at Oregon State Hospital, Elaine worked in Junction City, Oregon until Aug 2020. Prior to joining Oregon State Hospital, Elaine was a Vice President at Life Technologies and held the position of Vice President at Eugene, Oregon. Prior to that, Elaine was a Vice President, Commercial Development at Diosynth, based in Research Triangle Park, North Carolina from Feb 2000 to Aug 2002. Elaine started working as Vice President at Novartis in Summit / East Hanover, New Jersey in Nov 1983.
You can find Elaine Snowhill's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Elaine Snowhill's current jobs
Elaine Snowhill's past jobs
Established program management function for Molecular Probes Inc., Led R&D for Molecular Probes business. Created Global Project and Portfolio Management, led business and cultural integrations of multiple acquisitions, served as Chief of Staff for Cellular Analysis Business Unit for Invitrogen Corp. Oversaw project management and integration of nine concurrent global acquisitions, created and monitored processes to ensure integrity of global moves decisions for Life Technologies acquisitions.
Led business strategy development and implementation, served as Executive Liaison to key clients, established and led Program Management for all commercial projects, served on U.S. Executive Team. Facilitated project team, executive leadership, and customers to capture value in collaborations.
Created global project and portfolio management function and processes, implemented decision analysis into global R&D portfolio prioritization and selection processes, led Strategic Planning for U.S. Pharmaceuticals business. Conducted clinical research with new drug candidates for epilepsy; Managed regulatory affairs for new central nervous system (CNS) drug candidates and marketed drugs; performed basic R&D on new CNS candidates. Led Faster Time To Market change project which resulted in a 50% reduction in the time required to fully complete drug development and submit a new drug application to the FDA.